In the August issue of Genetic Engineering & Biotechnology News, Biocytogen’s RenMab™ (fully human antibody mouse) and RenLite® (common light chain) models are introduced in the article, as well as a case study using RenMab™ to generate timely monoclonal antibody treatment of COVID-19 infections.
Read the full article: https://www.genengnews.com/sponsored/novel-mice-models-produce-fully-human-antibodies/
Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Launched in 1980, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new technologies and applications, investment growth, and career opportunities. With nearly 40 years of publishing experience, GEN maintains unrivaled integrity, influence, and expertise that plays a pivotal role in driving the productivity and growth of the industry.